Table 1.
Baseline characteristics of patients in the comparator arm of the MPACT trial
| Characteristic | Patient statistics, n (%) |
|---|---|
| Age, years | |
| Median | 63 |
| Range | 32–88 |
| Sex | |
| Female | 173 (40) |
| Male | 257 (60) |
| Race (self‐reported) | |
| White | 401 (93) |
| Black | 16 (4) |
| Asian | 9 (2) |
| Other | 4 (1) |
| Region | |
| North America | 271 (63) |
| Eastern Europe | 62 (14) |
| Australia | 59 (14) |
| Western Europe | 38 (9) |
| Karnofsky Performance Status | |
| 100 | 70 (16) |
| 90 | 191 (45) |
| 80 | 135 (31) |
| 70 | 33 (8) |
| 60 | 0 (0) |
| Pancreatic tumor location | |
| Head | 180 (42) |
| Body | 136 (32) |
| Tail | 110 (26) |
| Unknown | 4 (1) |
| Number of organs with metastasis | |
| 1 | 21 (5) |
| 2 | 206 (48) |
| 3 | 140 (33) |
| 4+ | 63 (15) |
| Metastasis in: | |
| Liver | 360 (84) |
| Lung | 184 (43) |
| Bone | 18 (4) |
| Peritoneum | 10 (2) |